Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / ARCT - Arcturus rises 6% on $63.2M award from U.S. government for mRNA vaccine

ARCT - Arcturus rises 6% on $63.2M award from U.S. government for mRNA vaccine

Arcturus Therapeutics Ltd.

  • Arcturus Therapeutics ( NASDAQ: ARCT ) said on Wednesday it had obtained an award for up to $63.2M from the Biomedical Advanced Research and Development Authority.
  • ( ARCT ) rose ~6% after the bell.
  • The award will be provided over three years to support preclinical, manufacturing, nonclinical safety studies, along with development and regulatory support for Arcturus’ mRNA vaccine platform technology for rapid pandemic influenza response through Phase 1 clinical studies.
  • Arcturus’ mRNA platform has been administered to over 10,000 individuals.
  • The project has been supported in whole or in part with federal funds from the Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response; Biomedical Advanced Research and Development Authority.

For further details see:

Arcturus rises 6% on $63.2M award from U.S. government for mRNA vaccine
Stock Information
Company Name: Arcturus Therapeutics Ltd.
Stock Symbol: ARCT
Market: NASDAQ
Website: arcturusrx.com
Menu
ARCT ARCT Quote ARCT Short ARCT News ARCT Articles ARCT Message Board
Get ARCT Alerts

News, Short Squeeze, Breakout and More Instantly...